Invesaro

Stocks CYCU Financial statements

Financial statements

Cycurion, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Cycurion, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2022FY2023FY2024FY2025
Revenue19.417.815.1
Cost of revenue16.714.113.5
Gross profit2.643.631.61
Research and development00
Selling, general and administrative2.321.219.26
Operating expenses1.2225
Operating income-2.020.332.42-23.4
Interest expense2.071.211.76
Interest income1.570.370.02
Other non-operating income1.57-2.42-1.19-0.64
Pre-tax income-0.45-2.091.23-24.1
Income tax0.25000
Net income to minority interests0-0.39
Net income-0.7-2.11.23-23.7
EBITDA0.352.43-23.4
EPS, basic-11.624.35-13.44
EPS, diluted-11.621.66-13.39
Shares, basic (weighted)0.180.281.76
Shares, diluted (weighted)0.180.91.76

Balance sheet

FY2022FY2023FY2024FY2025
Cash and equivalents0.810.610.045.26
Receivables7.0910.42.69
Other current assets0.270.060.10.06
Total current assets1.088.4110.98
Property, plant and equipment0.030.020
Goodwill6.596.5920.8
Intangible assets0.040.030
Total assets11820.825.633.5
Accounts payable0.832.071.681.31
Accrued liabilities2.162.934.23
Deferred revenue0.25
Short-term debt0.2
Total current liabilities14.118.716.9
Total liabilities1.2415.520.217.2
Paid-in capital1.619.686.6747
Retained earnings-1.86-4.43-3.2-26.9
Shareholders' equity5.025.253.4720.1
Minority interests0-3.86
Total equity5.025.253.4716.2
Total liabilities and equity11820.825.633.5
Shares outstanding3.250.090.393.64

Cash flow statement

FY2022FY2023FY2024FY2025
Net income-0.7-2.11.23-24.1
Depreciation and amortization0.030.010.02
Stock-based compensation0.330.013.9
Change in payables1.073.110.91-0.84
Cash from operations-1.32-1.99-1.37-12.1
Capital expenditures-0.01-0.45-0.46
Cash from investing-116-0.71-0.891.41
Stock issued-0.08
Share buybacks-1140-1
Cash from financing1183.211.6915.9
Net change in cash0.810.51-0.575.21
Free cash flow-2-1.82-12.5
Interest paid0.5
Income taxes paid-0.25

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.81 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin17.2%Gross profit / revenue.
Operating margin-95.9%Operating income / revenue.
EBITDA margin-95.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-105.0%Pre-tax income / revenue.
Net margin-98.0%Net income / revenue.
FCF margin-86.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-83.0%Cash from operations / revenue.
Return on equity (ROE)-61.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-36.8%Net income / average total assets.
Return on invested capital (ROIC)-52.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue84.1%Selling, general and administrative expense / revenue.
Stock-based pay / revenue24.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.3%Capital expenditures / revenue.
D&A / revenue0.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-14.8%Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y-55.6%Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y-1,069.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-1,063.0%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-2,025.0%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-906.6%EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y479.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y58.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y30.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-34.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y94.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.30xCurrent assets / current liabilities.
Quick ratio0.29x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.10x(Cash + short-term investments) / current liabilities.
Liabilities / assets52.5%Total liabilities / total assets.
Interest coverage-9.85xOperating income / interest expense.
Working capital-$13.6MCurrent assets - current liabilities.
Goodwill and intangibles / assets72.0%(Goodwill + intangible assets) / total assets.
Tangible book value-$4.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.38xRevenue / average total assets.
Receivables turnover3.87xRevenue / average receivables.
Days sales outstanding94 days365 x average receivables / revenue.
Days payables40 days365 x average accounts payable / cost of revenue.

Per share

MetricValueHow it is calculated
EPS, diluted-$1.56Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$1.59Revenue / diluted weighted shares.
FCF per share-$1.37Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.32Cash from operations / diluted weighted shares.
Book value per share$1.92Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.41Tangible book value / shares outstanding.
Cash per share$0.16(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$72.6MShare price x shares outstanding.
Enterprise value$70.7MMarket cap + total debt - cash - short-term investments.
P/S5.04xMarket cap / revenue.
P/B3.19xMarket cap / shareholders' equity. Only when equity is positive.
EV/Sales4.91xEnterprise value / revenue.
FCF yield-17.1%Free cash flow / market cap.
Earnings yield-19.4%Net income / market cap (the inverse of P/E).
Shareholder yield0.0%(Dividends paid + share buybacks) / market cap.
What was Cycurion, Inc.'s revenue in fiscal 2025?

Cycurion, Inc. reported revenue of $15.1M for fiscal 2025, 14.8% lower than the year before.

Was Cycurion, Inc. profitable in fiscal 2025?

No. It reported a net loss of $23.7M.

How much free cash flow did Cycurion, Inc. generate in fiscal 2025?

Cash from operations of $12.1M minus capital expenditures of $455.0K left free cash flow of -$12.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Cycurion, Inc.